# OnCo record paper-marina-lancet-oncol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-marina-lancet-oncol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-marina-lancet-oncol" ;
  schema:name "Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial"@en ;
  schema:description "Paper cited by one cancer page and one trial page, indexed on Europe PMC as PubMed record 27569442 and published in The Lancet Oncology; the citing pages link this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-marina-lancet-oncol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(16)30214-5>, <https://pubmed.ncbi.nlm.nih.gov/27569442/>, <https://europepmc.org/article/MED/27569442> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(16)30214-5> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Marina NM, Smeland S, Bielack SS, et al." ;
  onco:related <https://onco.cc/cancers/osteosarcoma/> ;
  onco:trials <https://onco.cc/trials/euramos-1/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .
